How we use our IP
Here are some examples of spin-out and joint venture companies created using the University of Bradford's Intellectual Property:
Incanthera
Incanthera is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer which originally arose from the University of Bradford’s Institute for Cancer Therapeutics in 2010. Research on a new chemical entity called ICT2588, which has been designed to attack all forms of solid tumours while leaving healthy tissue unharmed.
Incanthera floated on London’s AQSE Growth Market in February 2020 and has a current lead product and focus on Sol, a potentially innovative topical product for the treatment of solar keratosis and the prevention of skin cancers.
CrystecPharma
CrystecPharma applies the latest supercritical fluid technology to improve the performance of medicines. They provide crystal and particle engineering solutions to the pharmaceutical industry, contributing to human health by enabling new and more effective therapies. Applications of Crystec technology include enhancing the dissolution and bioavailability of drugs, optimising release profiles, as well as improving stability and processing characteristics.
SARgard
SARgard Ltd is developing a technology originally developed in the Faculty of Engineering and Informatics technology revolves around a patented printed electronics product in the form of a screen protector which can redirect Specific Absorbed Radiation (SAR) from a mobile phone. Currently, the company is developing an initial prototype with the Centre for Process Innovation in Durham and is currently seeking funding to bring the product to market or to the point of production prototype and licensing to a distributor.
Bradford Metallurgy
Bradford Metallurgy has developed a revolutionary patented ‘Bradford Process’ capable of producing a wide range of metal powders: titanium, tantalum, hafnium, and transition and rare earth metals including their alloys for use in both conventional and emerging markets such as additive manufacturing. The ‘Bradford Process’ is observed to be faster and cheaper than the Kroll process, which is the current market leading process and accounts for almost 80% of titanium production.